TAS-109

TAS-109 · Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS-109, covering 2011-08-17 to 2011-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer [Phase 2]